Arkolith/Insider Trading/NBRV/Form 4

Schroeder Theodore R

Chief Executive Officer, DirectorNabriva Therapeutics plc (NBRV) · full profile →Form 4 · filed Aug 15, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 11, 2022Option exercise(M)120K—$0120K
Aug 11, 2022Option exercise(M)240K—$0240K
Aug 11, 2022Option exercise(M)120K—$00
Aug 11, 2022Option exercise(M)240K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-091492) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML